此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。

Culturally Appropriate Strategies for Chinese Americans With Diabetes (CASCADe)

2021年2月2日 更新者：Claremont Graduate University

Implementation and Evaluation of A Culturally Tailored Diabetes Self-Management Program for Chinese Americans

The project aimed to evaluate the implementation process and efficacy of a culturally tailored Diabetes Self-Management and Education (DSME) program with mobile health (mHealth) technology integration, entitled Culturally Appropriate Strategies for Chinese Americans with Diabetes (CASCADe), among Chinese American adults with Type 2 diabetes.

研究概览

地位

完全的

条件

干预/治疗

详细说明

The CASCADe program includes 1) a home visit for training of monitoring devices use, WeChat app and acquiring family support, 2) 8 weekly education sessions with a combined format of group class, games, food demonstration, group exercise, video and discussion, 3) WeChat follow-up on education tips, monitoring data summary, and group discussion. The monitoring system used a smartphone to coordinate cloud data transmission from a set of wireless devices to capture daily monitoring data on physical activity, body weight, blood pressure and blood glucose levels. WeChat app was used to facilitate behavioral self-monitoring by providing daily messages related to diabetes education curriculum, weekly summary reports on monitoring data as well as reinforcement messages and group discussion on readings and monitoring results implication. A single group pre-post-test design was adopted to evaluate changes of primary (HbA1c) and secondary (Self-efficacy, quality of life and stress coping) outcomes assessed at pre and post of intervention. Engagement and adherence in education sessions and self-monitoring system, and satisfaction with the content and delivery of intervention were also evaluated at the end of the study.

研究类型

介入性

注册 (实际的)

14

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习地点

  • 美国
    • California
      • Claremont、California、美国、91711
        • Clarement Graduate University

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

21年 至 75年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • have been diagnosed with Type 2 diabetes
  • having been managing diabetes with diet, oral hypoglycemic agents or insulin, or both
  • confirmed HbA1c level >=6.5% and <10%
  • 21-75 years old
  • residents of San Gabriel Valley
  • speak and understand of Mandarin
  • willing to use the smartphone-based monitoring devices provided by the project.

Exclusion Criteria:

  • unable or unwilling to give informed consent
  • plan to move out of the area within the 1-year participation study period
  • are or plan to be pregnant or breastfeeding in the next 12 months
  • have a condition that inhibits movement (e.g., unable to walk unaided, or cannot walk 1/4 mile without stopping)
  • have major physical disability or condition that prevents them from participating in person.

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

  • 主要用途：治疗
  • 分配：不适用
  • 介入模型：单组作业
  • 屏蔽：无（打开标签）

武器和干预

参与者组/臂
干预/治疗
实验性的：CASCADe Intervention
Intervention consisted of eight weekly sessions of health education and diabetes management. Topics covered include recognition of diabetes and its complications, risk factors, nutrition knowledge, dietary practices, exercise, behavioral self-monitoring, medication adherence, and stress management. Intervention also included a home visit for training of monitoring devices use, WeChat app and acquiring family support, and weekly WeChat follow-up on education tips, monitoring data summary, and group discussion. The monitoring system used a smartphone to coordinate cloud data transmission from a set of wireless devices to capture daily monitoring data on physical activity, body weight, blood pressure and blood glucose levels.
行为的：CASCADe
Culturally tailored diabetes self-management and education sessions with mHealth integration

研究衡量的是什么？

主要结果指标

结果测量
措施说明
大体时间
Change of Concentration of HbA1c
大体时间：Change from baseline HbA1c at 3 months
HbA1c was assessed using the testing kit of A1C Now+ with a finger prick of blood by trained data collector.
Change from baseline HbA1c at 3 months

次要结果测量

结果测量
措施说明
大体时间
Change of Score of Self-efficacy
大体时间：Change from baseline Self-efficacy score at 3 months
Chinese version of diabetes self-management self-efficacy scale included 20 items with likert-like response scale of 1-5 and minimum score of 20 and maximum score of 100.
Change from baseline Self-efficacy score at 3 months
Change of Score of Quality of life
大体时间：Change from baseline Quality of life score at 3 months
Chinese version of diabetes quality of life scale included 15 items with likert-like response scale of 1-5, and minimum score of 15 and maximum score of 75. .
Change from baseline Quality of life score at 3 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

Claremont Graduate University

合作者

AHMC Health Foundation

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2016年7月5日

初级完成 (实际的)

2018年2月15日

研究完成 (实际的)

2018年3月20日

研究注册日期

首次提交

2021年1月28日

首先提交符合 QC 标准的

2021年2月2日

首次发布 (实际的)

2021年2月4日

研究记录更新

最后更新发布 (实际的)

2021年2月4日

上次提交的符合 QC 标准的更新

2021年2月2日

最后验证

2021年1月1日

更多信息

与本研究相关的术语

关键字

其他相关的 MeSH 术语

其他研究编号

  • CGU IRB#2522

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)？

是的

IPD 计划说明

De-identified datasets with individual participant data will be provided by the Principal Investigator upon request. All data sharing requests will be reviewed and approved by the Office of Research and Sponsored Programs at Claremont Graduate University and the research investigating team.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.

订阅